# Henghai Kaiwu Engineering

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/henghai-kaiwu-engineering

- Industry: Biotechnology
- Headquarters: Tianjin, China
- Latest round: Angel (Jan 15, 2026)
- Investors on record: 3

## About

Based in Tianjin, China and founded in 2025, Tianjin Heng Hai Kai Wu Engineering Technology Co., Ltd., trading as Henghai Kaiwu Engineering, is a biomanufacturer primarily engaged in the research and development and production of food, health products, new chemical materials, and enzyme preparations, based on its proprietary in vitro biotransformation (iVBT) technology.  In January 2026, Henghai Kaiwu Engineering raised an Angel funding from new investors Renai Capital, Rianlon Corporation and Shangshi Fund.
The company’s products includes food, health products, and new chemical materials, as well as related enzyme preparations, based on its proprietary in vitro biotransformation (iVBT) new biomanufacturing platform.
The company’s revenue is generated by providing food, health products, new chemical materials, and enzyme preparations.
The Angel round of financing will be primarily used for technology research and development, team building, and market expansion.

## Funding rounds

- Angel, Jan 15, 2026 — Rianlon Corporation, Shangshi Fund, Renai Capital

## Investors

- Rianlon Corporation — Angel
- Shangshi Fund (https://capitalatlas.ai/funds/shangshi-fund) — Angel
- Renai Capital (https://capitalatlas.ai/funds/renai-capital) — Angel